サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1603899

コンパートメント症候群治療市場の2030年までの予測：治療タイプ別、投与経路別、エンドユーザー別、地域別の世界分析

Compartment Syndrome Treatment Market Forecasts to 2030 - Global Analysis by Treatment Type, Route of Administration, End User and By Geography

出版日
ページ情報
英文 200+ Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
コンパートメント症候群治療市場の2030年までの予測：治療タイプ別、投与経路別、エンドユーザー別、地域別の世界分析
出版日: 2024年11月11日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、コンパートメント症候群治療の世界市場は、2024年に2億2,250万米ドルを占め、予測期間中にCAGR 9.4％で成長し、2030年には3億8,140万米ドルに達すると予想されています。

コンパートメント症候群治療では、組織の損傷を防ぐために筋肉区画内の圧力を軽減することを目指します。主な治療法は筋膜切開術であり、筋肉を包む結合組織である筋膜を切開することで圧力を緩和し、正常な血液循環を回復させるための外科手術です。これは、血管、筋肉、神経を傷つけ、四肢の機能喪失や永続的な障害を引き起こすことを避けるために行われます。極端な状況では、筋膜切開術の後に、他の外科手術や創傷治療が行われることもあります。コンパートメント症候群を未治療のままにしておくと、筋肉や神経に不可逆的な損傷を与える可能性があるため、早期の診断と治療が不可欠です。

全米安全評議会（NSC）によると、2022年の運動器具による負傷者数は445,642人と推定され、スポーツ・レクリエーションカテゴリーの中で最も多いです。

増加する外傷と怪我の症例

骨折、事故、スポーツ関連傷害などの外傷・傷害事例の増加は、タイムリーな医療介入の需要を促進することにより、コンパートメント症候群治療市場に大きな影響を与えます。これらの傷害の発生率が上昇するにつれて、コンパートメント症候群を管理するための筋膜切開術やその他の外科的処置のような治療の必要性が高まります。この動向は市場の拡大を加速させ、ヘルスケアシステムはこの症状に対処するために専門的な治療と高度な診断ツールを優先させるため、最終的に患者の転帰を改善し、市場の成長に拍車をかけます。

高い治療費

手術、診断検査、術後ケアなどを含むコンパートメント症候群の高額な治療費は、特に低所得地域や保険未加入者にとっては、タイムリーで効果的な治療への患者のアクセスを著しく制限する可能性があります。この経済的な障壁は、診断の遅れ、患者の転帰の悪化、回復期間の長期化を招く可能性があります。その結果、高額な治療費が、特に十分な治療を受けていない地域における市場成長の抑制要因となっています。

手術技術の進歩

低侵襲筋膜切開術や術後ケアの改善といった手術技術の進歩は、治療効果を高め回復期間を短縮することで、コンパートメント症候群治療にプラスの影響を与えます。これらの技術革新は、より正確な介入を可能にし、合併症を最小限に抑え、より早い治癒を促します。その結果、患者は転帰を改善し、ヘルスケアプロバイダーはより効率的なケアを提供することができます。このような高度な技術の採用は市場の成長を促進し、専門的な治療に対する需要を高め、全体的な患者の満足度と回復率を向上させる。

合併症とリスク

感染、神経損傷、回復の長期化など、コンパートメント症候群治療に伴う合併症やリスクは、患者や医療提供者の足かせとなり、市場に悪影響を及ぼす可能性があります。これらの潜在的な有害結果は、治療導入率の低下、ヘルスケアコストの増加、回復期間の長期化につながる可能性があります。その結果、合併症は市場の成長と患者の転帰に脅威をもたらし、市場の成長を阻害します。

COVID-19の影響：

COVID-19は、ヘルスケアシステムに負担をかけ、手術を遅らせ、選択的手術を減らすことで、コンパートメント症候群治療市場に影響を与えました。COVID-19治療に注力した結果、外傷や救急症例へのリソースが制限され、転帰が悪化する可能性があった。しかし、パンデミックはヘルスケア・インフラ整備の必要性も浮き彫りにし、技術革新を促し、長期的には先進的な治療や技術に対する需要を増加させました。

予測期間中、理学療法分野が最大となる見込み

理学療法分野は、予測期間中に最大となる見込みです。手術後、理学療法は筋力、可動性、機能の回復を助け、長期的な障害を最小限に抑えます。早期の介入は循環を改善し、瘢痕組織の形成を抑え、組織の治癒を促進します。コンパートメント症候群治療市場における理学療法サービスの需要は、その利点に対する認識が高まるにつれて増加し、早期回復、患者のQOL向上、効果的なリハビリテーションによる医療費削減をサポートします。

予測期間中、非経口投与セグメントのCAGRが最も高くなると予想される

非経口療法分野は、効果的な疼痛管理と重要な回復をサポートすることから、予測期間中に最も高いCAGRが見込まれます。静脈内輸液、抗生物質、鎮痛薬は、患者の安定化、炎症の抑制、筋膜切開やその他の外科手術後の感染予防のために一般的に使用されます。非経口療法を用いることで、緊急時に不可欠な薬剤の迅速な投与が可能となります。これにより、患者の転帰が改善され、合併症が減少し、回復が早まるため、非経口治療はコンパートメント症候群を効果的に管理する上で極めて重要な要素となっています。

最大のシェアを占める地域

北米は、外傷の増加、技術開拓、ヘルスケア専門家の意識の向上、有利な償還政策により、予測期間中最大の市場シェアを占めると予測されます。最新のモニタリングシステムと低侵襲手術法は、回復を早め治療効果を高めている技術開発の2つの例です。加えて、医療従事者がこの疾患に関する知識を深めているため、迅速な診断と治療が可能となっています。

CAGRが最も高い地域：

アジア太平洋地域は、洗練された手術方法と技術によって患者の予後を改善しているため、予測期間中に最も高いCAGRを示すと予測されます。筋膜切開術のような早期診断と治療は、認知度の向上とヘルスケアへのアクセスの改善により、より一般的に行われるようになり、問題を軽減し回復を早める。その結果、この疾患の持続的な制限は減少しています。さらに、市場の拡大は技術革新を刺激し、雇用機会を生み出し、医学研究を支援し、地域の全体的なヘルスケア・インフラを強化しています。

無料のカスタマイズ提供：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場企業の包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査情報源
    • 1次調査情報源
    • 2次調査情報源
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • エンドユーザー分析
  • 新興市場
  • COVID-19の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界のコンパートメント症候群治療市場：治療タイプ別

  • 手術
    • 筋膜切開術
    • 減圧手術
  • 支持治療
  • 抗炎症薬
  • 理学療法

第6章 世界のコンパートメント症候群治療市場：投与経路別

  • 経口
  • 非経口
  • 静脈注射

第7章 世界のコンパートメント症候群治療市場：エンドユーザー別

  • 病院
  • 外来手術センター
  • リハビリテーションセンター
  • 整形外科クリニック
  • 小売薬局
  • オンライン薬局
  • その他のエンドユーザー

第8章 世界のコンパートメント症候群治療市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第9章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品発売
  • 事業拡大
  • その他の主要戦略

第10章 企業プロファイリング

  • Zimmer Biomet
  • Stryker Corporation
  • DePuy Synthes
  • Smith & Nephew
  • B. Braun Melsungen AG
  • Medtronic
  • Conmed Corporation
  • 3M Health Care
  • Integra LifeSciences
  • Bioventus
  • Orthofix Medical Inc.
  • Arthrex, Inc.
  • Teleflex Incorporated
  • Smith & Nephew
  • KCI Medical
図表

List of Tables

  • Table 1 Global Compartment Syndrome Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Compartment Syndrome Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Compartment Syndrome Treatment Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 4 Global Compartment Syndrome Treatment Market Outlook, By Fasciotomy (2022-2030) ($MN)
  • Table 5 Global Compartment Syndrome Treatment Market Outlook, By Decompression Surgery (2022-2030) ($MN)
  • Table 6 Global Compartment Syndrome Treatment Market Outlook, By Supportive Treatment (2022-2030) ($MN)
  • Table 7 Global Compartment Syndrome Treatment Market Outlook, By Anti-Inflammatory Medications (2022-2030) ($MN)
  • Table 8 Global Compartment Syndrome Treatment Market Outlook, By Physiotherapy (2022-2030) ($MN)
  • Table 9 Global Compartment Syndrome Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 10 Global Compartment Syndrome Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 11 Global Compartment Syndrome Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
  • Table 12 Global Compartment Syndrome Treatment Market Outlook, By Intravenous (2022-2030) ($MN)
  • Table 13 Global Compartment Syndrome Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 14 Global Compartment Syndrome Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 15 Global Compartment Syndrome Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 16 Global Compartment Syndrome Treatment Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 17 Global Compartment Syndrome Treatment Market Outlook, By Orthopedic Clinics (2022-2030) ($MN)
  • Table 18 Global Compartment Syndrome Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 19 Global Compartment Syndrome Treatment Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 20 Global Compartment Syndrome Treatment Market Outlook, By Other End users (2022-2030) ($MN)
  • Table 21 North America Compartment Syndrome Treatment Market Outlook, By Country (2022-2030) ($MN)
  • Table 22 North America Compartment Syndrome Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 23 North America Compartment Syndrome Treatment Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 24 North America Compartment Syndrome Treatment Market Outlook, By Fasciotomy (2022-2030) ($MN)
  • Table 25 North America Compartment Syndrome Treatment Market Outlook, By Decompression Surgery (2022-2030) ($MN)
  • Table 26 North America Compartment Syndrome Treatment Market Outlook, By Supportive Treatment (2022-2030) ($MN)
  • Table 27 North America Compartment Syndrome Treatment Market Outlook, By Anti-Inflammatory Medications (2022-2030) ($MN)
  • Table 28 North America Compartment Syndrome Treatment Market Outlook, By Physiotherapy (2022-2030) ($MN)
  • Table 29 North America Compartment Syndrome Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 30 North America Compartment Syndrome Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 31 North America Compartment Syndrome Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
  • Table 32 North America Compartment Syndrome Treatment Market Outlook, By Intravenous (2022-2030) ($MN)
  • Table 33 North America Compartment Syndrome Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 34 North America Compartment Syndrome Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 35 North America Compartment Syndrome Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 36 North America Compartment Syndrome Treatment Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 37 North America Compartment Syndrome Treatment Market Outlook, By Orthopedic Clinics (2022-2030) ($MN)
  • Table 38 North America Compartment Syndrome Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 39 North America Compartment Syndrome Treatment Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 40 North America Compartment Syndrome Treatment Market Outlook, By Other End users (2022-2030) ($MN)
  • Table 41 Europe Compartment Syndrome Treatment Market Outlook, By Country (2022-2030) ($MN)
  • Table 42 Europe Compartment Syndrome Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 43 Europe Compartment Syndrome Treatment Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 44 Europe Compartment Syndrome Treatment Market Outlook, By Fasciotomy (2022-2030) ($MN)
  • Table 45 Europe Compartment Syndrome Treatment Market Outlook, By Decompression Surgery (2022-2030) ($MN)
  • Table 46 Europe Compartment Syndrome Treatment Market Outlook, By Supportive Treatment (2022-2030) ($MN)
  • Table 47 Europe Compartment Syndrome Treatment Market Outlook, By Anti-Inflammatory Medications (2022-2030) ($MN)
  • Table 48 Europe Compartment Syndrome Treatment Market Outlook, By Physiotherapy (2022-2030) ($MN)
  • Table 49 Europe Compartment Syndrome Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 50 Europe Compartment Syndrome Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 51 Europe Compartment Syndrome Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
  • Table 52 Europe Compartment Syndrome Treatment Market Outlook, By Intravenous (2022-2030) ($MN)
  • Table 53 Europe Compartment Syndrome Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 54 Europe Compartment Syndrome Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 55 Europe Compartment Syndrome Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 56 Europe Compartment Syndrome Treatment Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 57 Europe Compartment Syndrome Treatment Market Outlook, By Orthopedic Clinics (2022-2030) ($MN)
  • Table 58 Europe Compartment Syndrome Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 59 Europe Compartment Syndrome Treatment Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 60 Europe Compartment Syndrome Treatment Market Outlook, By Other End users (2022-2030) ($MN)
  • Table 61 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Country (2022-2030) ($MN)
  • Table 62 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 63 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 64 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Fasciotomy (2022-2030) ($MN)
  • Table 65 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Decompression Surgery (2022-2030) ($MN)
  • Table 66 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Supportive Treatment (2022-2030) ($MN)
  • Table 67 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Anti-Inflammatory Medications (2022-2030) ($MN)
  • Table 68 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Physiotherapy (2022-2030) ($MN)
  • Table 69 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 70 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 71 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
  • Table 72 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Intravenous (2022-2030) ($MN)
  • Table 73 Asia Pacific Compartment Syndrome Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 74 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 75 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 76 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 77 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Orthopedic Clinics (2022-2030) ($MN)
  • Table 78 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 79 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 80 Asia Pacific Compartment Syndrome Treatment Market Outlook, By Other End users (2022-2030) ($MN)
  • Table 81 South America Compartment Syndrome Treatment Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 South America Compartment Syndrome Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 83 South America Compartment Syndrome Treatment Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 84 South America Compartment Syndrome Treatment Market Outlook, By Fasciotomy (2022-2030) ($MN)
  • Table 85 South America Compartment Syndrome Treatment Market Outlook, By Decompression Surgery (2022-2030) ($MN)
  • Table 86 South America Compartment Syndrome Treatment Market Outlook, By Supportive Treatment (2022-2030) ($MN)
  • Table 87 South America Compartment Syndrome Treatment Market Outlook, By Anti-Inflammatory Medications (2022-2030) ($MN)
  • Table 88 South America Compartment Syndrome Treatment Market Outlook, By Physiotherapy (2022-2030) ($MN)
  • Table 89 South America Compartment Syndrome Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 90 South America Compartment Syndrome Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 91 South America Compartment Syndrome Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
  • Table 92 South America Compartment Syndrome Treatment Market Outlook, By Intravenous (2022-2030) ($MN)
  • Table 93 South America Compartment Syndrome Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 94 South America Compartment Syndrome Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 95 South America Compartment Syndrome Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 96 South America Compartment Syndrome Treatment Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 97 South America Compartment Syndrome Treatment Market Outlook, By Orthopedic Clinics (2022-2030) ($MN)
  • Table 98 South America Compartment Syndrome Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 99 South America Compartment Syndrome Treatment Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 100 South America Compartment Syndrome Treatment Market Outlook, By Other End users (2022-2030) ($MN)
  • Table 101 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Country (2022-2030) ($MN)
  • Table 102 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 103 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Surgery (2022-2030) ($MN)
  • Table 104 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Fasciotomy (2022-2030) ($MN)
  • Table 105 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Decompression Surgery (2022-2030) ($MN)
  • Table 106 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Supportive Treatment (2022-2030) ($MN)
  • Table 107 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Anti-Inflammatory Medications (2022-2030) ($MN)
  • Table 108 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Physiotherapy (2022-2030) ($MN)
  • Table 109 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 110 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 111 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Parenteral (2022-2030) ($MN)
  • Table 112 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Intravenous (2022-2030) ($MN)
  • Table 113 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 114 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 115 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 116 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Rehabilitation Centers (2022-2030) ($MN)
  • Table 117 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Orthopedic Clinics (2022-2030) ($MN)
  • Table 118 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Retail Pharmacies (2022-2030) ($MN)
  • Table 119 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Online Pharmacies (2022-2030) ($MN)
  • Table 120 Middle East & Africa Compartment Syndrome Treatment Market Outlook, By Other End users (2022-2030) ($MN)
目次
Product Code: SMRC27921

According to Stratistics MRC, the Global Compartment Syndrome Treatment Market is accounted for $222.5 million in 2024 and is expected to reach $381.4 million by 2030 growing at a CAGR of 9.4% during the forecast period. Compartment syndrome treatment seeks to reduce pressure within muscle compartments in order to prevent tissue injury. The main course of treatment is fasciotomy, which is a surgical operation used to relieve pressure and restore normal blood circulation by cutting open the fascia, the connective tissue that surrounds muscles. This is done to avoid harming the blood vessels, muscles, and nerves, which could result in loss of limb function or permanent impairment. In extreme situations, fasciotomy may be followed by other surgical operations and wound care. Since untreated compartment syndrome can cause irreversible damage to muscles and nerves, early diagnosis and treatments are essential.

According to the National Safety Council (NSC), exercise equipment accounted for an estimated 445,642 injuries in 2022, the highest number in any sports and recreation category.

Market Dynamics:

Driver:

Increasing Trauma and Injury Cases

The increasing cases of trauma and injury, such as fractures, accidents, and sports-related injuries, significantly impact the compartment syndrome treatment market by driving demand for timely medical interventions. As the incidence of these injuries rises, the need for treatments like fasciotomy and other surgical procedures to manage compartment syndrome grows. This trend accelerates market expansion, as healthcare systems prioritize specialized care and advanced diagnostic tools to address the condition, ultimately improving patient outcomes and fueling market growth.

Restraint:

High Treatment Costs

High treatment costs for compartment syndrome, which include surgery, diagnostic tests, and post-operative care, can significantly limit patient access to timely and effective treatment, particularly in low-income regions or for those without insurance. This financial barrier may result in delayed diagnosis, worsening patient outcomes, and longer recovery periods. As a result, high treatment costs act as a restraint on the growth of the market, particularly in underserved areas.

Opportunity:

Advancements in Surgical Techniques

Advancements in surgical techniques, such as minimally invasive fasciotomy and improved postoperative care, positively impact the compartment syndrome treatment by enhancing treatment efficacy and reducing recovery times. These innovations allow for more precise interventions, minimizing complications and promoting faster healing. As a result, patients experience improved outcomes, and healthcare providers can offer more efficient care. The adoption of these advanced techniques drives market growth, increases demand for specialized treatments, and enhances overall patient satisfaction and recovery rates.

Threat:

Complications and Risks

Complications and risks associated with compartment syndrome treatments, such as infection, nerve damage, and prolonged recovery, can negatively impact the market by deterring patients and healthcare providers. These potential adverse outcomes may lead to lower treatment adoption rates, increased healthcare costs, and longer recovery periods. As a result, complications pose a threat to market growth and patient outcomes, thus it hinders the growth of the market.

Covid-19 Impact:

COVID-19 impacted the compartment syndrome treatment market by straining healthcare systems, delaying surgeries, and reducing elective procedures. The focus on COVID-19 care led to limited resources for trauma and emergency cases, potentially worsening outcomes. However, the pandemic also highlighted the need for improved healthcare infrastructure, driving innovation and increasing the demand for advanced treatments and technologies in the long term.

The physiotherapy segment is expected to be the largest during the forecast period

The physiotherapy segment is expected to be the largest during the forecast period as Post-surgery; physiotherapy helps restore muscle strength, mobility, and function, minimizing long-term disability. Early intervention improves circulation, reduces scar tissue formation, and promotes tissue healing. As awareness of its benefits grows, demand for physiotherapy services in the compartment syndrome treatment market increases, supporting faster recovery, improving quality of life for patients, and reducing healthcare costs through effective rehabilitation.

The parenteral segment is expected to have the highest CAGR during the forecast period

The parenteral segment is expected to have the highest CAGR during the forecast period owing to effective pain management and supporting critical recovery. Intravenous (IV) fluids, antibiotics, and analgesics are commonly used to stabilize patients, control inflammation, and prevent infection following fasciotomy or other surgical procedures. The use of parenteral therapies ensures rapid delivery of medications, which is essential in emergency situations. This improves patient outcomes, reduces complications, and accelerates recovery, making parenteral treatments a crucial component in managing compartment syndrome effectively.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to rising traumatic injuries, technological developments, higher awareness among healthcare professionals, and favorable reimbursement policies. Modern monitoring systems and minimally invasive surgical methods are two examples of technological developments that are speeding up recovery and increasing treatment results. Additionally, medical personnel are growing more knowledgeable about the disorder, which enables prompt diagnosis and treatment.

Region with highest CAGR:

Asia Pacific is projected to witness the highest CAGR over the forecast period because it improves patient outcomes using sophisticated surgical methods and technology. Early diagnosis and treatment, like fasciotomy, are more commonly available due to more awareness and improved access to healthcare, which lowers problems and speeds up recovery. As a result, the condition's lasting limitations have decreased. Furthermore, the expanding market stimulates innovation, generating employment opportunities, supporting medical research, and enhancing the region's overall healthcare infrastructure.

Key players in the market

Some of the key players in Compartment Syndrome Treatment Market include Zimmer Biomet, Stryker Corporation, DePuy Synthes, Smith & Nephew, B. Braun Melsungen AG, Medtronic, Conmed Corporation, 3M Health Care, Integra LifeSciences, Bioventus, Orthofix Medical Inc., Arthrex, Inc., Teleflex Incorporated, Smith & Nephew and KCI Medical.

Key Developments:

In October 2024, 3M has launched the second season of 3M Clash of the Grinders, a video series featuring a head-to-head metalworking and welding competition that brings together the best and brightest students from welding schools across the United States.

In October 2024, 3M expanded its commitment to consumer safety and hearing protection with the launch of 3M(TM) WorkTunes(TM) Connect + Solar Hearing Protector.

In April 2024, 3M launched new verify app to help tackle counterfeit personal protective equipment. The app helps validate a disposable respirator carton in real time by using advanced technology to identify a bar code and determine if a product package is genuine.

Treatment Types Covered:

  • Surgery
  • Supportive Treatment
  • Anti-Inflammatory Medications
  • Physiotherapy

Route of Administrations Covered:

  • Oral
  • Parenteral
  • Intravenous

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Rehabilitation Centers
  • Orthopedic Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Other End users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Compartment Syndrome Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Surgery
    • 5.2.1 Fasciotomy
    • 5.2.2 Decompression Surgery
  • 5.3 Supportive Treatment
  • 5.4 Anti-Inflammatory Medications
  • 5.5 Physiotherapy

6 Global Compartment Syndrome Treatment Market, By Route of Administration

  • 6.1 Introduction
  • 6.2 Oral
  • 6.3 Parenteral
  • 6.4 Intravenous

7 Global Compartment Syndrome Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Ambulatory Surgical Centers
  • 7.4 Rehabilitation Centers
  • 7.5 Orthopedic Clinics
  • 7.6 Retail Pharmacies
  • 7.7 Online Pharmacies
  • 7.8 Other End users

8 Global Compartment Syndrome Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Zimmer Biomet
  • 10.2 Stryker Corporation
  • 10.3 DePuy Synthes
  • 10.4 Smith & Nephew
  • 10.5 B. Braun Melsungen AG
  • 10.6 Medtronic
  • 10.7 Conmed Corporation
  • 10.8 3M Health Care
  • 10.9 Integra LifeSciences
  • 10.10 Bioventus
  • 10.11 Orthofix Medical Inc.
  • 10.12 Arthrex, Inc.
  • 10.13 Teleflex Incorporated
  • 10.14 Smith & Nephew
  • 10.15 KCI Medical